Data as of Apr 17
| -0.11 / -0.86%|
The 9 analysts offering 12-month price forecasts for Durata Therapeutics Inc have a median target of 19.00, with a high estimate of 22.00 and a low estimate of 13.00. The median estimate represents a +49.96% increase from the last price of 12.67.
The current consensus among 9 polled investment analysts is to Buy stock in Durata Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.